Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 11. Effects of oral labetalol in patients with both angina pectoris and hypertension: a preliminary experience
- 1 March 1980
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 99 (3) , 388-396
- https://doi.org/10.1016/0002-8703(80)90354-3
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 7. New horizons in beta-adrenoceptor blockade therapy: LabetalolAmerican Heart Journal, 1979
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applicationsAmerican Heart Journal, 1979
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effectsAmerican Heart Journal, 1979
- Coronary-Artery SpasmNew England Journal of Medicine, 1978
- Competition between sympathetic vasoconstriction and metabolic vasodilation in the canine coronary circulation.Circulation Research, 1978
- Tonic influence of the sympathetic nervous system on myocardial reactive hyperemia and on coronary blood flow distribution in dogs.Circulation Research, 1977
- Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.Circulation, 1977
- Reflex Increase in Coronary Vascular Resistance in Patients with Ischemic Heart DiseaseNew England Journal of Medicine, 1976
- Adrenergic Receptor Activity in the Coronary Arteries of the Unanesthetized DogCirculation Research, 1967
- Relation of Heart Rate and Systolic Blood Pressure to the Onset of Pain in Angina PectorisCirculation, 1967